

HY-P1698B · 5 mg
MedChemExpress · Cat: HY-P1698B
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/reltecimod-tfa.htmlDescription
Reltecimod AB-103 TFA is a T-cell-specific surface glycoprotein CD28 TP44 antagonist. Reltecimod TFA has beneficial effects against different bacterial infections, their exotoxins and endotoxins, and ionizing radiation. Reltecimod TFA modulates the inflammatory response by targeting and attenuating the critical CD28/B7-2 co-stimulatory pathway, without inhibiting it. Reltecimod TFA can be used to research necrotizing soft-tissue infections NSTIs .